Inventor · disambiguated record
Philip Anthony Morganelli
Also filed as: MORGANELLI PHILIP A · MORGANELLI PHILIP ANTHONY
22 granted patents·4 pending applications·162 citations·filing 2010–2023
95Inventor score
Top patents by PatentIndex Score
26 records- 0196US9522912B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2015·Granted Dec 20, 2016·21 cites·53 claims
- 0295US11773122B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·4 cites·38 claims
- 0395US11420974B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Aug 23, 2022·4 cites·33 claims
- 0494US9732092B2Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2016·Granted Aug 15, 2017·11 cites·16 claims
- 0594US8884030B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Nov 11, 2014·29 cites·18 claims
- 0693US10836769B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·6 cites·53 claims
- 0793US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 0893US10035809B2Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2017·Granted Jul 31, 2018·10 cites·3 claims
- 0993US8524764B2Inhibitors of Flaviviridae virusesCANALES EDA·Filed 2011·Granted Sep 3, 2013·29 cites·20 claims
- 1090US8513298B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2011·Granted Aug 20, 2013·14 cites·2 claims
- 1188US10689399B2Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infectionsGILEAD SCIENCES INC·Filed 2018·Granted Jun 23, 2020·2 cites·4 claims
- 1288US8569302B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2010·Granted Oct 29, 2013·14 cites·20 claims
- 1387US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 1487US9795602B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2016·Granted Oct 24, 2017·4 cites·18 claims
- 1586US9321753B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Apr 26, 2016·8 cites·19 claims
- 1682US12030904B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 1780US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 1877US11963967B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Apr 23, 2024·0 cites·51 claims
- 1976US12473314B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 2074US11548901B2Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infectionsGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·0 cites·21 claims
- 2173US2023148157A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2270US2021251957A1Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2368US2021015816A1Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2466US12208110B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 2563US10646486B2Polycyclic-carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2017·Granted May 12, 2020·0 cites·20 claims
- 2652US2014030223A1Inhibitors of flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Anthony Morganelli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →